Prourocare Medical Inc. (PUMD) Return on Investment ROI from the third quarter of 2013 to third quarter of 2012 and for the year 2013, average high and low, overall ranking from Sep 30 2013 to Sep 30 2012 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Prourocare Medical Inc.  (PUMD)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Prourocare Medical's ROI from its third quarter of 2013 to the third quarter of 2012 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Prourocare Medical's ROI in the third quarter of 2013?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Prourocare Medical Inc.'s return on investment (ROI) in its third quarter of 2013

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -3 -4 -4 -4 -3
Return On Investment (TTM) - - - - -
PUMD's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -2 -2 -3 -3 -2

PUMD Company Profile >> Back to PUMD Roi Comparisons >> See Annual PUMD Return On Investment



Return On Investment PUMD's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Prourocare Medical's III. Quarter Investments $ -3 Millions PUMD's Balance sheet
Prourocare Medical's III. Quarter Income $ 0 Millions Quarterly PUMD's Income Statement
PUMD's Income by Division See PUMD's Income by Division


PUMD Annual Return On Investment (Dec 31 2012)
2012		 (Dec 31 2011)
2011


Total Investments in Millions -4 -2 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions -3 -2 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PUMD's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PUMD's Competitors
Subscribers only: Roi for Prourocare Medical's Suppliers
Subscribers only: Return On Investment for PUMD's Customers

Other Ratios
PUMD's Roa PUMD's Inventory Turnover Ratio PUMD's Growth Rates PUMD's Dividend Statistics
PUMD's Profitability Ratios PUMD's Asset Turnover Ratio PUMD's Dividend Growth
PUMD's Roe PUMD's Valuation Ratios PUMD's Financial Strength Ratios PUMD's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2013, within Healthcare Sector ROI
Brainstorm Cell Therapeutics inc   111.50 %
Telik Inc  91.60 %
China Yct International Group, Inc.  75.14 %
Oramed Pharmaceuticals Inc  74.57 %
Pacific Health Care Organization Inc  52.95 %
Veru Inc   52.33 %
Camp4 Therapeutics Corporation  39.20 %
Regeneron Pharmaceuticals Inc   38.47 %
Fonar Corporation  33.07 %
Cellular Biomedicine Group Inc   30.28 %
Acorda Therapeutics Inc   29.96 %
Idexx Laboratories Inc  28.81 %
China Biologic Products Holdings Inc   28.55 %
Sunlink Health Systems Inc   26.80 %
Psychemedics Corporation  25.90 %
Meridian Bioscience Inc   25.53 %
Myriad Genetics Inc   25.37 %
Elite Pharmaceuticals Inc   24.60 %
Biospecifics Technologies Corp  24.17 %
Abbvie Inc   22.87 %
Varian Medical Systems Inc   22.29 %
Repligen Corp  22.15 %
Nutrastar International Inc.  21.17 %
Nrc Health  20.81 %
United Therapeutics Corporation  20.64 %
Mettler toledo International Inc   20.59 %
Edwards Lifesciences Corporation  20.12 %
Biogen Inc   20.08 %
Lifevantage Corp  19.80 %
Addus Homecare Corp  19.52 %

Date modified: 2026-09-08T15:07:33+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.